BRAF and colitis: Similarly, a small study of 16 patients with BRAF-mutated metastatic melanoma treated with vemurafenib/ipilimumab combination therapy who underwent 18F-FDG-PET/CT detected 7 patients developing at least one irAE (most frequently colitis and arthritis) (146).